Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

VERONA PHARMA PLC

(VRNA)
  Report
Delayed Nasdaq  -  04:00 2022-10-03 pm EDT
10.11 USD   -1.08%
09/30European ADRs Move Higher in Friday Trading
MT
09/27European ADRs Climb Higher in Tuesday Trading
MT
09/22European ADRs Move Lower in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Higher in Tuesday Trading

08/09/2022 | 11:03am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 0.47% 1.08 Delayed Quote.-71.20%
AMARIN CORPORATION PLC 2.75% 1.12 Delayed Quote.-66.77%
ARGENX SE -1.90% 361.5 Real-time Quote.14.65%
BICYCLE THERAPEUTICS PLC -1.42% 22.93 Delayed Quote.-62.33%
BIONTECH SE 1.33% 136.68 Delayed Quote.-47.68%
CARNIVAL CORPORATION -2.56% 6.85 Delayed Quote.-65.06%
CELLECTIS S.A. -4.53% 2.318 Real-time Quote.-68.84%
ERYTECH PHARMA S.A. 3.48% 0.58 Real-time Quote.-72.64%
LONDON BRENT OIL 0.70% 89.36 Delayed Quote.9.50%
MORPHOSYS AG 1.22% 20.81 Delayed Quote.-37.60%
NOVO NORDISK A/S 1.60% 773.6 Delayed Quote.3.59%
NUCANA PLC -2.39% 1.02 Delayed Quote.-56.09%
SHELL PLC 2.36% 2299.5 Delayed Quote.41.79%
SPARK NETWORKS SE 8.90% 2.08 Delayed Quote.-33.76%
TRIVAGO N.V. -0.86% 1.15 Delayed Quote.-47.25%
VERONA PHARMA PLC -1.08% 10.11 Delayed Quote.50.45%
WPP PLC -0.08% 749.4 Delayed Quote.-33.06%
WTI 0.78% 83.979 Delayed Quote.8.90%
All news about VERONA PHARMA PLC
09/30European ADRs Move Higher in Friday Trading
MT
09/27European ADRs Climb Higher in Tuesday Trading
MT
09/22European ADRs Move Lower in Thursday Trading
MT
09/19Wedbush Analyst Assumes Coverage on Verona Pharma at Outperform With $27 Price Target, ..
MT
09/16European ADRs Move Lower in Friday Trading
MT
09/13European ADRs Drop Sharply in Tuesday Trading
MT
09/09European ADRs Rise Sharply in Friday Trading
MT
09/07European ADRs Move Lower in Wednesday Trading
MT
09/06European ADRs Move Higher in Tuesday Trading
MT
09/01Verona Pharma : VRNA Investor Presentation September 2022
PU
More news
Analyst Recommendations on VERONA PHARMA PLC
More recommendations
Financials
Sales 2022 5,91 M 6,68 M 6,68 M
Net income 2022 -61,4 M -69,4 M -69,4 M
Net cash 2022 167 M 188 M 188 M
P/E ratio 2022 -14,4x
Yield 2022 -
Capitalization 784 M 886 M 886 M
EV / Sales 2022 104x
EV / Sales 2023 87,9x
Nbr of Employees 25
Free-Float 92,8%
Chart VERONA PHARMA PLC
Duration : Period :
Verona Pharma plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VERONA PHARMA PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 10,11 $
Average target price 26,00 $
Spread / Average Target 157%
EPS Revisions
Managers and Directors
David S. Zaccardelli President, CEO & Executive Director
Mark W. Hahn Chief Financial Officer
David Raymond Ebsworth Non-Executive Chairman
Kathleen Rickard Chief Medical Officer
Tara Rheault Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
VERONA PHARMA PLC50.45%886
GILEAD SCIENCES, INC.-14.17%77 320
VERTEX PHARMACEUTICALS35.44%74 255
REGENERON PHARMACEUTICALS, INC.16.41%73 646
BIONTECH SE-47.68%32 778
WUXI APPTEC CO., LTD.-39.54%29 044